Literature DB >> 8683154

The signaling activity of murine CD19 is regulated during cell development.

I Krop1, A L Shaffer, D T Fearon, M S Schlissel.   

Abstract

CD19, a B cell-specific transmembrane protein, is essential for murine B-1 cell development and T cell-dependent B cell immune responses. Whereas signaling by the human B cell Ag receptor can be modulated by CD19, less is known about the biochemical properties of murine CD19. We have used a novel rat mAb specific for murine CD19 to study the biochemical properties of the murine protein. We demonstrate that murine CD19 shares with human CD19 an association with complement receptor CD21 and CD81, tyrosine phosphorylation, binding of phosphatidylinositol-3 kinase, and synergistic signaling with membrane IgM. Murine CD19 is shown also to enhance signaling through the micro-surrogate light chain complex of primary pre-B cells. We found that although expressed in the earliest B cell precursors, CD19 ligation does not activate Ca2+ mobilization until the pre-B cell stage of development. In mature B cells, CD19 cross-linking activates Ca2+ flux in B-2 cells but not in B-1 cells, although it can synergize with surface IgM in both B-1 and B-2 cells. These biochemical properties of CD19 will be important for understanding its function in B cell development and the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683154

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities.

Authors:  Francesco Del Galdo; Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

2.  Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Chiung-Chi Kuo; Joseph Haimovich; Shoshana Levy
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels.

Authors:  Amanda R Hajek; Alexa R Lindley; Silvio Favoreto; Roderick Carter; Robert P Schleimer; Douglas A Kuperman
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

4.  The effects of c-Abl mutation on developing B cell differentiation and survival.

Authors:  Hans Brightbill; Mark S Schlissel
Journal:  Int Immunol       Date:  2009-03-19       Impact factor: 4.823

5.  Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.

Authors:  Luke R Donius; Christopher M Orlando; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2013-08-21       Impact factor: 3.144

6.  CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody.

Authors:  Farrukh T Awan; Rosa Lapalombella; Rossana Trotta; Jonathan P Butchar; Bo Yu; Don M Benson; Julie M Roda; Carolyn Cheney; Xiaokui Mo; Amy Lehman; Jeffrey Jones; Joseph Flynn; David Jarjoura; John R Desjarlais; Susheela Tridandapani; Michael A Caligiuri; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2009-12-02       Impact factor: 22.113

7.  A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.

Authors:  Jonathan C Poe; Veronique Minard-Colin; Evgueni I Kountikov; Karen M Haas; Thomas F Tedder
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

8.  Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.

Authors:  Jason Twohig; Liudmila Kulik; Catherine Haluszczak; Jason Reuter; Andreas Rossbach; Melanie Bull; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

9.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

10.  CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.

Authors:  Karen M Haas; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.